Brooklyn Investment Group’s iTeos Therapeutics ITOS Stock Holding History

Brooklyn Investment Group’s Portfolio ITOS Stock Details ITOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-556	Closed	-$5.54K	–	1671
2025 Q2	$5.54K	Buy	+556	New	+$4.48K	﹤0.01%	2427
2025 Q1	–	Sell	-533	Closed	-$4.09K	–	2824
2024 Q4	$4.09K	Buy	+533	New	+$4.58K	﹤0.01%	1282

Other funds holding ITOS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Brooklyn Investment Group's ITOS Position: Q3 2025 in Review

Brooklyn Investment Group sold out of iTeos Therapeutics (ITOS) in Q3 2025, closing a stake of 556 shares — an estimated $5.54K sold.

Brooklyn Investment Group first reported a position in ITOS in Q4 2024 and held it in 2 quarters. The position peaked at $5.54K in Q2 2025. 1 fund tracked by Wall St. Rank holds ITOS as of Q3 2025.

Brooklyn Investment Group reported no remaining iTeos Therapeutics position as of Q3 2025 after selling out during the quarter.
Brooklyn Investment Group sold 556 iTeos Therapeutics shares in Q3 2025, an estimated $5.54K.
Brooklyn Investment Group first reported a position in iTeos Therapeutics in Q4 2024 and held it in 2 quarters.
Brooklyn Investment Group's iTeos Therapeutics position peaked at $5.54K in Q2 2025.
1 fund tracked by Wall St. Rank held iTeos Therapeutics as of Q3 2025.

Based on Brooklyn Investment Group's 13F filing for Q3 2025, filed 14 Nov 2025.